These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31768272)

  • 1. Haemodynamic Balance in Acute and Advanced Heart Failure: An Expert Perspective on the Role of Levosimendan.
    Agostoni P; Farmakis DT; García-Pinilla JM; Harjola VP; Karason K; von Lewinski D; Parissis J; Pollesello P; Pölzl G; Recio-Mayoral A; Reinecke A; Yerly P; Zima E
    Card Fail Rev; 2019 Nov; 5(3):155-161. PubMed ID: 31768272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inotropes in Advanced Heart Failure: The Last Tool in the Box of Failures?
    Haider L; Mewton N
    Cardiology; 2024 May; ():1-2. PubMed ID: 38781936
    [No Abstract]   [Full Text] [Related]  

  • 3. Inotropic Agents: Are We Still in the Middle of Nowhere?
    Iorio AM; Lucà F; Pozzi A; Rao CM; Di Fusco SA; Colivicchi F; Grimaldi M; Oliva F; Gulizia MM
    J Clin Med; 2024 Jun; 13(13):. PubMed ID: 38999301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. REVOLUTION in Heart Failure Care and SELECT Highlights From the European Society of Cardiology-Heart Failure Association Heart Failure & World Congress on Acute Heart Failure 2024.
    Reza N; Pellicori P; Starling RC
    J Card Fail; 2024 Jun; ():. PubMed ID: 38838982
    [No Abstract]   [Full Text] [Related]  

  • 5. Short-term treatments for acute cardiac care: inotropes and inodilators.
    Guarracino F; Zima E; Pollesello P; Masip J
    Eur Heart J Suppl; 2020 May; 22(Suppl D):D3-D11. PubMed ID: 32431568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Levosimendan on cardiac function, size and strain in heart failure patients.
    Beitzke D; Gremmel F; Senn D; Laggner R; Kammerlander A; Wielandner A; Nolz R; Hülsmann M; Loewe C
    Int J Cardiovasc Imaging; 2021 Mar; 37(3):1063-1071. PubMed ID: 33103224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on levosimendan in acute cardiac care: applications and recommendations for optimal efficacy and safety.
    Heringlake M; Alvarez J; Bettex D; Bouchez S; Fruhwald S; Girardis M; Grossini E; Guarracino F; Herpain A; Toller W; Tritapepe L; Pollesello P
    Expert Rev Cardiovasc Ther; 2021 Apr; 19(4):325-335. PubMed ID: 33739204
    [No Abstract]   [Full Text] [Related]  

  • 8. Levosimendan in the light of the results of the recent randomized controlled trials: an expert opinion paper.
    Cholley B; Levy B; Fellahi JL; Longrois D; Amour J; Ouattara A; Mebazaa A
    Crit Care; 2019 Nov; 23(1):385. PubMed ID: 31783891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levosimendan or dobutamine in patients with low cardiac output syndrome: Results from meta-analysis.
    Jaguszewski MJ; Gasecka A; Filipiak KJ; Szarpak L
    Int J Cardiol; 2021 Jun; 333():145. PubMed ID: 33639185
    [No Abstract]   [Full Text] [Related]  

  • 10. Inotropic agents in cardiogenic shock.
    Polyzogopoulou E; Arfaras-Melainis A; Bistola V; Parissis J
    Curr Opin Crit Care; 2020 Aug; 26(4):403-410. PubMed ID: 32496275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levosimendan Reduces Mortality and Low Cardiac Output Syndrome in Cardiac Surgery.
    Weber C; Esser M; Eghbalzadeh K; Sabashnikov A; Djordjevic I; Maier J; Merkle J; Choi YH; Madershahian N; Liakopoulos O; Deppe AC; Wahlers TCW
    Thorac Cardiovasc Surg; 2020 Aug; 68(5):401-409. PubMed ID: 31770777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Development of Levosimendan in Acute and Advanced Heart Failure: A Systematic Review.
    Desai HN; Sangurima L; Malik MM; Ganatra N; Siby R; Kumar S; Khan S; Jayaprakasan SK; Cheriachan D; Mohammed L
    Cureus; 2023 Apr; 15(4):e37844. PubMed ID: 37214028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Levosimendan in Patients with Pulmonary Hypertension: What is the Current Evidence?
    Masarone D; Kittleson M; Pollesello P; Tedford RJ; Pacileo G
    Drugs; 2023 Feb; 83(3):195-201. PubMed ID: 36652192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Levosimendan in Patients with Advanced Heart Failure: An Update.
    Masarone D; Kittleson MM; Pollesello P; Marini M; Iacoviello M; Oliva F; Caiazzo A; Petraio A; Pacileo G
    J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levosimendan in Europe and China: An Appraisal of Evidence and Context.
    Kong X; Hu X; Hua B; Fedele F; Farmakis D; Pollesello P
    Eur Cardiol; 2021 Feb; 16():e42. PubMed ID: 34815750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of levosimendan, NO, and inhaled iloprost for pulmonary hypertension reversibility assessment in heart transplant candidates.
    Tavares-Silva M; Saraiva F; Pinto R; Amorim S; Silva JC; Leite-Moreira AF; Maciel MJ; Lourenço AP
    ESC Heart Fail; 2021 Apr; 8(2):908-917. PubMed ID: 33621427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use.
    Papp Z; Agostoni P; Alvarez J; Bettex D; Bouchez S; Brito D; Černý V; Comin-Colet J; Crespo-Leiro MG; Delgado JF; Édes I; Eremenko AA; Farmakis D; Fedele F; Fonseca C; Fruhwald S; Girardis M; Guarracino F; Harjola VP; Heringlake M; Herpain A; Heunks LM; Husebye T; Ivancan V; Karason K; Kaul S; Kivikko M; Kubica J; Masip J; Matskeplishvili S; Mebazaa A; Nieminen MS; Oliva F; Papp JG; Parissis J; Parkhomenko A; Põder P; Pölzl G; Reinecke A; Ricksten SE; Riha H; Rudiger A; Sarapohja T; Schwinger RH; Toller W; Tritapepe L; Tschöpe C; Wikström G; von Lewinski D; Vrtovec B; Pollesello P
    Card Fail Rev; 2020 Mar; 6():e19. PubMed ID: 32714567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use.
    Papp Z; Agostoni P; Alvarez J; Bettex D; Bouchez S; Brito D; Černý V; Comin-Colet J; Crespo-Leiro MG; Delgado JF; Édes I; Eremenko AA; Farmakis D; Fedele F; Fonseca C; Fruhwald S; Girardis M; Guarracino F; Harjola VP; Heringlake M; Herpain A; Heunks LMA; Husebye T; Ivancan V; Karason K; Kaul S; Kivikko M; Kubica J; Masip J; Matskeplishvili S; Mebazaa A; Nieminen MS; Oliva F; Papp JG; Parissis J; Parkhomenko A; Põder P; Pölzl G; Reinecke A; Ricksten SE; Riha H; Rudiger A; Sarapohja T; Schwinger RHG; Toller W; Tritapepe L; Tschöpe C; Wikström G; Lewinski DV; Vrtovec B; Pollesello P
    J Cardiovasc Pharmacol; 2020 Jul; 76(1):4-22. PubMed ID: 32639325
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.